Achieve life sciences to announce first quarter 2025 financial results and host conference call and webcast on may 13, 2025

Seattle and vancouver, british columbia, may 06, 2025 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that it will report its first quarter 2025 financial results and provide a corporate update on the cytisinicline development program on tuesday may 13, 2025, at 8:30 am edt.
ACHV Ratings Summary
ACHV Quant Ranking